It's been 8 months since I last heard from you. How about you?

(0) 讚！ | Mirabelle

Review speed: 6.0 | Submission hit rate: 75.0
Experience sharing: Very slow, carefully select articles to hurry out

(0) 讚！ | 虎鹤平松

2022年 IF=2.032

(0) 讚！ | 努力啊大白山

Jian Lu, Peiyuan Li, Xuezhi Du, Yanhong Liu, Baotong Zhang, Feng Qi; Regulatory T cells induce transplant immune tolerance; PMID: 34020045 DOI: 10.1016/j.trim.2021.101411

(0) 讚！ | 努力啊大白山

Acceptance

(0) 讚！ | 努力啊大白山

Hello, may I ask if this magazine accepts reviews? Specifically on the topic of kidney transplant rejection

(0) 讚！ | 宏盛三岁啦

I feel like it was a pretty quick pace, I accepted it in less than a month

(0) 讚！ | 苍风连荣

No, I invested on 2.28, but I still don't have a number. He said they need to conduct a preliminary review before assigning the numbers

(0) 讚！ | 苍风连荣

Does each author need to be determined? Why isn't there a manuscript number?

(0) 讚！ | 苍风连荣

ORCID is an open researcher and contributor ID system, operated by a non-profit organization. An ORCID ID is a unique and persistent academic identifier for authors, enabling them to differentiate themselves from other researchers and to track all of their research activities.

Researchers can register for an ORCID ID for free at https://orcid.org/signin by providing their name, email address, and creating a password

(0) 讚！ | 维尔娜菲茨杰拉德

What is ORCID ID? How do I register?

(0) 讚！ | 龙鳞孝礼

Not needed

(0) 讚！ | 努力啊大白山

Fast review, nice editors, professional journals in the field of transplantation, recommended

(0) 讚！ | 凤凰院芊丽

Hello, I would like to ask if there is a layout fee needed?

(0) 讚！ | 韦陀新真

The latest IF=1.708

(0) 讚！ | 努力啊大白山

2021-4-24 Submitted to Journal
2021-4-26 With Editor
2021-4-28 Under Review
2021-5-13 Under Review
2021-5-14 Revise (Minor Revise)
2021-5-14 re-Submitted to Journal
2021-5-14 With Editor
2021-5-17 Accept
The Under Review stage changed twice, I don't know what's going on. In the end, there was only one reviewer and only one comment.
Our lab has submitted several papers to this journal, and all have been accepted. The key is the fast review speed and high acceptance rate

(0) 讚！ | 努力啊大白山

Currently, I have submitted a review article to the journal. 

2021-4-24: Submitted to Journal
2021-4-26: Under Editor's Review
2021-4-28: Under Review
2021-5-13: Still Under Review
2021-5-14: Revision (Minor Revision)
2021-5-14: Re-submitted to Journal
2021-5-14: Under Editor's Review
2021-5-17: Accepted

During the first review stage, there were two changes in the "Under Review" timeline, and I'm not sure of the reason. In the end, there was only one reviewer, who provided only one comment.

Our laboratory has submitted several articles to this journal, and all of them have been accepted. The key factor is the extremely fast review process and high acceptance rate.

(0) 讚！ | 能帮我发SCI嘛

Submitted another review on organ transplantation, hoping for good news!

(0) 讚！ | 努力啊大白山

The reviewing speed is really fast. Our laboratory has already had several articles accepted, with extremely fast reviewing process. (IF=1.624; Q3 zone)

2021/01/29 submitted to journal

2021/02/01 With Editor

2021/02/01 Under Review

2021/02/04 Required Reviews Completed

2021/02/04 minor revision

2021/02/05 re-submitted

2021/02/05 accepted

(1) 讚！ | 能帮我发SCI嘛

Lu J, Liu Y, Wang W, Li P, Qi F. Knockdown of miR-146a in regulatory T cells suppresses heart transplantation rejection in mice by increasing autophagy [J]. Transpl Immunol, 2021, 101372

(0) 讚！ | 努力啊大白山

Organ transplant, from submission to publication, takes only half a month

(0) 讚！ | 努力啊大白山

Which side did you bet on, it was so quick

(0) 讚！ | 凤凰院芊丽

Received, from submission to acceptance, in less than a week

(0) 讚！ | 努力啊大白山

Submitted, 2 days later, it becomes "with editor," and 2 hours later, it becomes "under review."

(0) 讚！ | 努力啊大白山

Just submitted an article, hoping for good news

(0) 讚！ | 努力啊大白山